Current FDA-Approved Therapies for High-Grade Malignant Gliomas
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004675/
WEBMar 22, 2021 · Outside of TMZ, there are four drugs and one device FDA-approved for the treatment of HGGs: lomustine, intravenous carmustine, carmustine wafer implants, bevacizumab (BVZ), and tumor treatment fields (TTFields). These treatments are now mainly used to treat recurrent HGGs and symptoms.
DA: 36 PA: 29 MOZ Rank: 57